Application of CAR-T Cell Therapy beyond Oncology: Autoimmune Diseases and Viral Infections
Adoptive cell transfer (ACT) has long been at the forefront of the battle with cancer that began last century with the therapeutic application of tumor-infiltrating lymphocytes (TILs) against melanoma. The development of novel ACT approaches led researchers and clinicians to highly efficient technol...
Main Authors: | Ekaterina Zmievskaya, Aygul Valiullina, Irina Ganeeva, Alexey Petukhov, Albert Rizvanov, Emil Bulatov |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/1/59 |
Similar Items
-
Adoptive Immunotherapy beyond CAR T-Cells
by: Aleksei Titov, et al.
Published: (2021-02-01) -
Advancing CAR T-Cell Therapy for Solid Tumors: Lessons Learned from Lymphoma Treatment
by: Aleksei Titov, et al.
Published: (2020-01-01) -
Tuning the performance of CAR T cell immunotherapies
by: Noah H. Richardson, et al.
Published: (2019-11-01) -
Engineering switchable and programmable universal CARs for CAR T therapy
by: Delong Liu, et al.
Published: (2019-07-01) -
Autoimmunity in Wiskott-Aldrich Syndrome: an unsolved enigma
by: Marco eCatucci, et al.
Published: (2012-07-01)